Humacyte (HUMA) Assets Average (2020 - 2026)

Humacyte (HUMA) has 7 years of Assets Average data on file, last reported at $113.5 million in Q1 2026.

• Assets Average for Q1 2026 came in at $113.5 million, down 24.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $113.5 million (down 24.47% YoY), and the FY2025 annual result was $127.1 million, down 4.46% from the prior year.
• Assets Average advanced to $113.5 million in Q1 2026 per HUMA's latest filing, from $103.9 million in the prior quarter.
• Over five years, Assets Average peaked at $275.5 million in Q1 2022 and troughed at $103.9 million in Q4 2025.
• A 5-year average of $166.5 million and a median of $150.2 million in 2025 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2023: Assets Average surged 165.73% in 2022, then tumbled 35.52% in 2023.
• A 5-year view of Assets Average shows it stood at $215.3 million in 2022, then plunged by 35.52% to $138.8 million in 2023, then fell by 9.0% to $126.3 million in 2024, then retreated by 17.72% to $103.9 million in 2025, then gained by 9.16% to $113.5 million in 2026.
• Business Quant data shows HUMA's Assets Average at $113.5 million in Q1 2026, $103.9 million in Q4 2025, and $115.2 million in Q3 2025.